FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Tapio Visakorpi

Research Profile

Disorders

Procedures

Physiology

Chemicals & Drugs

Anatomy

Phenomena

Nucleic Acid Hybridization

Living Beings

Mouse

Co-author Network

Publications

TOP 3
Virpi H Laitinen; Heli Nevanlinna; Liisa M Pelttari; Tommi Rantapero; Leena Saaristo; Lauri Aaltonen; Anssi Auvinen; Anne Kallioniemi; Outi Kilpivaara; Satu-Leena Laasanen; Teuvo L J Tammela; Robert L Vessella; Tapio Visakorpi; Tiina Wahlfors; Johanna Schleutker
HOXB13 G84E mutation in Finland: population-based analysis of prostate, breast, and colorectal cancer risk.
Saara Lehmusvaara; Janne Seppälä; Teuvo L J Tammela; Alfonso Urbanucci; Timo Erkkilä; Sanni Jalava; Antti Kaipia; Paula Kujala; Harri Lähdesmäki; Tapio Visakorpi
Goserelin and bicalutamide treatments alter the expression of microRNAs in the prostate.
Takahiro Kimura; Jun Miki; Hiroyuki Takahashi; Geert J H L van Leenders; Tapio Visakorpi; Toshihiro Yamamoto; Bungo Furusato; Norihiro Hayashi; Yuko Kamata; Shin Egawa
Expression of ERG oncoprotein is associated with a less aggressive tumor phenotype in Japanese prostate cancer patients.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Tapio Visakorpi (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Virpi H Laitinen; Heli Nevanlinna; Liisa M Pelttari; Tommi Rantapero; Leena Saaristo; Lauri Aaltonen; Anssi Auvinen; Anne Kallioniemi; Outi Kilpivaara; Satu-Leena Laasanen; Teuvo L J Tammela; Robert L Vessella; Tapio Visakorpi; Tiina Wahlfors; Johanna Schleutker
HOXB13 G84E mutation in Finland: population-based analysis of prostate, breast, and colorectal cancer risk.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2013;22(3):452-60.
2013: Saara Lehmusvaara; Janne Seppälä; Teuvo L J Tammela; Alfonso Urbanucci; Timo Erkkilä; Sanni Jalava; Antti Kaipia; Paula Kujala; Harri Lähdesmäki; Tapio Visakorpi
Goserelin and bicalutamide treatments alter the expression of microRNAs in the prostate.
The Prostate 2013;73(1):101-12.
2012: Takahiro Kimura; Jun Miki; Hiroyuki Takahashi; Geert J H L van Leenders; Tapio Visakorpi; Toshihiro Yamamoto; Bungo Furusato; Norihiro Hayashi; Yuko Kamata; Shin Egawa
Expression of ERG oncoprotein is associated with a less aggressive tumor phenotype in Japanese prostate cancer patients.
Pathology international 2012;62(11):742-8.
2012: S E Jalava; O A Jänne; Harri Lähdesmäki; Leena Latonen; B Sahu; J Seppälä; T L J Tammela; A Urbanucci; Kati K Waltering; Tapio Visakorpi
Androgen-regulated miR-32 targets BTG2 and is overexpressed in castration-resistant prostate cancer.
Oncogene 2012;31(41):4460-71.
2012: Kati K Waltering; Alfonso Urbanucci; Tapio Visakorpi
Androgen receptor (AR) aberrations in castration-resistant prostate cancer.
Molecular and cellular endocrinology 2012;360(1-2):38-43.
2012: Antti Roine; Thanos Sioris; Miki Sipiläinen; Teuvo L Tammela; Mikko Tolvanen; Antti Tuokko; Jouko Vepsäläinen; Erik Veskimäe; Tapio Visakorpi; Merja R Häkkinen; Merja A Helenius; Hannu Helle; Tuomo A Keinänen; Juha Koskimäki; Pekka Kumpulainen; Terho Lehtimäki; Jukka Lekkala; Timo Paavonen; Niku K J Oksala
Detection of smell print differences between nonmalignant and malignant prostate cells with an electronic nose.
Future oncology (London, England) 2012;8(9):1157-65.
2011: Teemu T Tolonen; Vilppu J Tuominen; Jorma J Isola; Paula M Kujala; Teuvo L J Tammela; Tapio Visakorpi
Histopathological variables and biomarkers enhancer of zeste homologue 2, Ki-67 and minichromosome maintenance protein 7 as prognosticators in primarily endocrine-treated prostate cancer.
BJU international 2011;108(9):1430-8.
2011: Bungo Furusato; Masakuni Furusato; Shin Egawa; Takahiro Kimura; Hiroyuki Takahashi; Jan Trapman; Geert J H L van Leenders; Tapio Visakorpi; Hiroshi Hano
Immunohistochemical ETS-related gene detection in a Japanese prostate cancer cohort: diagnostic use in Japanese prostate cancer patients.
Pathology international 2011;61(7):409-14.
2011: Joost L Boormans; Kati Porkka; Tapio Visakorpi; Jan Trapman
Confirmation of the association of TMPRSS2(exon 0):ERG expression and a favorable prognosis of primary prostate cancer.
European urology 2011;60(1):183-4.
2011: Kati P Porkka; Erinn-Lee Ogg; Outi Saramäki; Robert L Vessella; Heidi Pukkila; Harri Lähdesmäki; Wytske M Van Weerden; Maija Wolf; Olli P Kallioniemi; Guido Jenster; Tapio Visakorpi
The miR-15a-miR-16-1 locus is homozygously deleted in a subset of prostate cancers.
Genes, chromosomes & cancer 2011;50(7):499-509.
2011: Kati K Waltering; Kati P Porkka; Sanni E Jalava; Alfonso Urbanucci; Pekka J Kohonen; Leena M Latonen; Olli P Kallioniemi; Guido Jenster; Tapio Visakorpi
Androgen regulation of micro-RNAs in prostate cancer.
The Prostate 2011;71(6):604-14.
2011: Teemu T Tolonen; Vilppu J Tuominen; Jorma J Isola; Paula M Kujala; Teuvo L J Tammela; Tapio Visakorpi
Overall and worst gleason scores are equally good predictors of prostate cancer progression.
BMC urology 2011;11():21.
2011: Anchit Khanna; Juha Okkeri; Turker Bilgen; Timo H Tiirikka; Mauno Vihinen; Tapio Visakorpi; Jukka Westermarck
ETS1 mediates MEK1/2-dependent overexpression of cancerous inhibitor of protein phosphatase 2A (CIP2A) in human cancer cells.
PloS one 2011;6(3):e17979.
2010: Hanna E Rauhala; Sanni E Jalava; Jarkko Isotalo; Hazel Bracken; Saara Lehmusvaara; Teuvo L J Tammela; Hannu Oja; Tapio Visakorpi
miR-193b is an epigenetically regulated putative tumor suppressor in prostate cancer.
International journal of cancer. Journal international du cancer 2010;127(6):1363-72.
2010: Hanna E Suikki; Paula M Kujala; Teuvo L J Tammela; Wytske M Van Weerden; Robert L Vessella; Tapio Visakorpi
Genetic alterations and changes in expression of histone demethylases in prostate cancer.
The Prostate 2010;70(8):889-98.
2010: Katri A Leinonen; Teemu T Tolonen; Hazel Bracken; Ulf-Håkan Stenman; Teuvo L J Tammela; Outi Saramäki; Tapio Visakorpi
Association of SPINK1 expression and TMPRSS2:ERG fusion with prognosis in endocrine-treated prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(10):2845-51.
2010: Lei Gu; Xian-Hua Zhu; Tapio Visakorpi; Kalle Alanen; Tuomas Mirtti; Tina Bocker Edmonston; Marja T Nevalainen
Activating mutation (V617F) in the tyrosine kinase JAK2 is absent in locally-confined or castration-resistant prostate cancer.
Analytical cellular pathology (Amsterdam) 2010;33(2):55-9.
2009: Visa Manni; Merja A Helenius; Biswajyoti Sahu; Visa Manni; Marika J Linja; Olli A Jänne; Tapio Visakorpi
Increased expression of androgen receptor sensitizes prostate cancer cells to low levels of androgens.
Cancer research 2009;69(20):8141-9.
2009: Marita Laurila; Teuvo L J Tammela; Anssi Auvinen; Jorma Isola; Tapio Visakorpi; Tiina Luukkaala; Liisa Määttänen; Mirja Ruutu; Martti Ala-Opas; Markus Mildh; Paula Martikainen
Biological aggressiveness of prostate cancer in the Finnish screening trial.
International journal of cancer. Journal international du cancer 2009;124(3):547-52.
2009: Outi Saramäki; Kati K Waltering; Tapio Visakorpi
Methods for identifying and studying genetic alterations in hormone-dependent cancers.
Methods in molecular biology (Clifton, N.J.) 2009;505():263-77.
2009: Sanni E Jalava; Kati P Porkka; Hanna E Rauhala; Jarkko Isotalo; Teuvo L J Tammela; Tapio Visakorpi
TCEB1 promotes invasion of prostate cancer cells.
International journal of cancer. Journal international du cancer 2009;124(1):95-102.
2008: Erkko Ylösmäki; Tanja Hakkarainen; Akseli Hemminki; Tapio Visakorpi; Raul Andino; Kalle Saksela
Generation of a conditionally replicating adenovirus based on targeted destruction of E1A mRNA by a cell type-specific MicroRNA.
Journal of virology 2008;82(22):11009-15.
2008: Hanna E Rauhala; Kati P Porkka; Outi Saramäki; Teuvo L J Tammela; Tapio Visakorpi
Clusterin is epigenetically regulated in prostate cancer.
International journal of cancer. Journal international du cancer 2008;123(7):1601-9.
2008: Teemu J Murtola; Tapio Visakorpi; Jorma Lahtela; Heimo Syvälä; Teuvo Lj Tammela
Statins and prostate cancer prevention: where we are now, and future directions.
Nature clinical practice. Urology 2008;5(7):376-87.
2008: Outi Saramäki; Anna E Harjula; Paula M Martikainen; Robert L Vessella; Teuvo L J Tammela; Tapio Visakorpi
TMPRSS2:ERG fusion identifies a subgroup of prostate cancers with a favorable prognosis.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(11):3395-400.
2008: Junaid Abdulghani; Lei Gu; Ayush Dagvadorj; Jacqueline Lutz; Benjamin Leiby; Gloria Bonuccelli; Michael P Lisanti; Tobias Zellweger; Kalle Alanen; Tuomas Mirtti; Tapio Visakorpi; Lukas Bubendorf; Marja T Nevalainen
Stat3 promotes metastatic progression of prostate cancer.
The American journal of pathology 2008;172(6):1717-28.
2008: Sari Laitinen; Paula M Martikainen; Teemu T Tolonen; Jorma Isola; Teuvo L J Tammela; Tapio Visakorpi
EZH2, Ki-67 and MCM7 are prognostic markers in prostatectomy treated patients.
International journal of cancer. Journal international du cancer 2008;122(3):595-602.
2008: Pia Alhopuro; Auli Karhu; Robert Winqvist; Kati K Waltering; Tapio Visakorpi; Lauri A Aaltonen
Somatic mutation analysis of MYH11 in breast and prostate cancer.
BMC cancer 2008;8():263.
2008: Alfonso Urbanucci; Kati K Waltering; Hanna E Suikki; Merja A Helenius; Tapio Visakorpi
Androgen regulation of the androgen receptor coregulators.
BMC cancer 2008;8():219.
2008: Shyh-Han Tan; Ayush Dagvadorj; Feng Shen; Lei Gu; Zhiyong Liao; Junaid Abdulghani; Ying Zhang; Edward P Gelmann; Tobias Zellweger; Zoran Culig; Tapio Visakorpi; Lukas Bubendorf; Robert A Kirken; James Karras; Marja T Nevalainen
Transcription factor Stat5 synergizes with androgen receptor in prostate cancer cells.
Cancer research 2008;68(1):236-48.
2007: Sari Laitinen; Paula M Martikainen; Teuvo L J Tammela; Tapio Visakorpi
Cellular changes in prostate cancer cells induced by intermittent androgen suppression.
European urology 2007;52(3):725-32.
2007: H E Mäki; Outi Saramäki; L Shatkina; Paula M Martikainen; Teuvo L J Tammela; Wytske M Van Weerden; Robert L Vessella; Andrew C B Cato; Tapio Visakorpi
Overexpression and gene amplification of BAG-1L in hormone-refractory prostate cancer.
The Journal of pathology 2007;212(4):395-401.
2007: Kati P Porkka; Minja J Pfeiffer; Kati K Waltering; Robert L Vessella; Teuvo L J Tammela; Tapio Visakorpi
MicroRNA expression profiling in prostate cancer.
Cancer research 2007;67(13):6130-5.
2007: Ayush Dagvadorj; Sean Collins; Jean-Baptiste Jomain; Junaid Abdulghani; James Karras; Tobias Zellweger; Hongzhen Li; Martti Nurmi; Kalle Alanen; Tuomas Mirtti; Tapio Visakorpi; Lukas Bubendorf; Vincent Goffin; Marja T Nevalainen
Autocrine prolactin promotes prostate cancer cell growth via Janus kinase-2-signal transducer and activator of transcription-5a/b signaling pathway.
Endocrinology 2007;148(7):3089-101.
2007: Clare L Scott; Jésus Gil; Eva Hernando; Julie T Feldstein; Masako Narita; Dolores Martínez; Tapio Visakorpi; David Mu; Carlos Cordon-Cardo; Gordon Peters; David Beach; Scott W Lowe
Role of the chromobox protein CBX7 in lymphomagenesis.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(13):5389-94.
2007: Marianthi Georgitsi; Auli Karhu; Robert Winqvist; Tapio Visakorpi; Kati K Waltering; Pia Vahteristo; Virpi Launonen; Lauri A Aaltonen
Mutation analysis of aryl hydrocarbon receptor interacting protein (AIP) gene in colorectal, breast, and prostate cancers.
British journal of cancer 2007;96(2):352-6.
2007: Tapio Visakorpi
[Not Available].
Duodecim; lääketieteellinen aikakauskirja 2007;123(11):1323-8.
2007: Outi Saramäki; Tapio Visakorpi
Chromosomal aberrations in prostate cancer.
Frontiers in bioscience : a journal and virtual library 2007;12():3287-301.
2006: Kati K Waltering; Mika J Wallén; Teuvo L J Tammela; Robert L Vessella; Tapio Visakorpi
Mutation screening of the androgen receptor promoter and untranslated regions in prostate cancer.
The Prostate 2006;66(15):1585-91.
2006: Hanna E Mäki; Kati K Waltering; Mika J Wallén; Paula M Martikainen; Teuvo L J Tammela; Wytske M Van Weerden; Robert L Vessella; Tapio Visakorpi
Screening of genetic and expression alterations of SRC1 gene in prostate cancer.
The Prostate 2006;66(13):1391-8.
2006: Outi Saramäki; Kati P Porkka; Robert L Vessella; Tapio Visakorpi
Genetic aberrations in prostate cancer by microarray analysis.
International journal of cancer. Journal international du cancer 2006;119(6):1322-9.
2006: Kimmo Savinainen; Merja A Helenius; Heli J Lehtonen; Tapio Visakorpi
Overexpression of EIF3S3 promotes cancer cell growth.
The Prostate 2006;66(11):1144-50.
2006: Outi Saramäki; Teuvo L J Tammela; Paula M Martikainen; Robert L Vessella; Tapio Visakorpi
The gene for polycomb group protein enhancer of zeste homolog 2 (EZH2) is amplified in late-stage prostate cancer.
Genes, chromosomes & cancer 2006;45(7):639-45.
2006: Merja A Helenius; Kimmo Savinainen; G Steven Bova; Tapio Visakorpi
Amplification of the urokinase gene and the sensitivity of prostate cancer cells to urokinase inhibitors.
BJU international 2006;97(2):404-9.
2005: Hanna E Rauhala; Kati P Porkka; Teemu T Tolonen; Paula M Martikainen; Teuvo L J Tammela; Tapio Visakorpi
Dual-specificity phosphatase 1 and serum/glucocorticoid-regulated kinase are downregulated in prostate cancer.
International journal of cancer. Journal international du cancer 2005;117(5):738-45.
2005: Harri Sihto; Marjut Puputti; Laura Pulli; Olli Tynninen; Walter J Koskinen; Leena-Maija Aaltonen; Minna Tanner; Tom Böhling; Tapio Visakorpi; Ralf Bützow; Aija Knuuttila; Nina N Nupponen; Heikki Joensuu
Epidermal growth factor receptor domain II, IV, and kinase domain mutations in human solid tumors.
Journal of molecular medicine (Berlin, Germany) 2005;83(12):976-83.
2005: Rute B Marques; Sigrun Erkens-Schulze; Corrina M A de Ridder; Karin G Hermans; Kati K Waltering; Tapio Visakorpi; Jan Trapman; Johannes C Romijn; Wytske M Van Weerden; Guido Jenster
Androgen receptor modifications in prostate cancer cells upon long-termandrogen ablation and antiandrogen treatment.
International journal of cancer. Journal international du cancer 2005;117(2):221-9.
2005: Leena Karenko; Sonja Hahtola; Suvi Päivinen; Ritva Karhu; Sanna Syrjä; Marketta Kähkönen; Boguslaw Nedoszytko; Soili Kytölä; Ying Zhou; Vesna Blazevic; Maria Pesonen; Hanna Nevala; Nina N Nupponen; Harri Sihto; Inge Krebs; Annemarie Poustka; Jadwiga Roszkiewicz; Kalle Saksela; Pärt Peterson; Tapio Visakorpi; Annamari Ranki
Primary cutaneous T-cell lymphomas show a deletion or translocation affecting NAV3, the human UNC-53 homologue.
Cancer research 2005;65(18):8101-10.
2005: David Bernard; Juan F Martinez-Leal; Sian Rizzo; Dolores Martinez; David Hudson; Tapio Visakorpi; Gordon Peters; Amancio Carnero; David Beach; Jesus Gil
CBX7 controls the growth of normal and tumor-derived prostate cells by repressing the Ink4a/Arf locus.
Oncogene 2005;24(36):5543-51.
2005: Mika Wallén; Eija Tomás; Tapio Visakorpi; Kaija Holli; Jukka Mäenpää
Endometrial K-ras mutations in postmenopausal breast cancer patients treated with adjuvant tamoxifen or toremifene.
Cancer chemotherapy and pharmacology 2005;55(4):343-6.
2004: Marika J Linja; Tapio Visakorpi
Alterations of androgen receptor in prostate cancer.
The Journal of steroid biochemistry and molecular biology 2004;92(4):255-64.
2004: Kati P Porkka; Tapio Visakorpi
Molecular mechanisms of prostate cancer.
European urology 2004;45(6):683-91.
2004: Kimmo Savinainen; Marika J Linja; Outi Saramäki; Teuvo L J Tammela; Glenn T G Chang; Albert O Brinkmann; Tapio Visakorpi
Expression and copy number analysis of TRPS1, EIF3S3 and MYC genes in breast and prostate cancer.
British journal of cancer 2004;90(5):1041-6.
2004: Ruoxiang Wang; Jianchun Xu; Outi Saramäki; Tapio Visakorpi; William M Sutherland; Jianguang Zhou; Buer Sen; So Dug Lim; Nicola J Mabjeesh; Mahul B Amin; Jin-Tang Dong; John Petros; Peter S Nelson; Fray F Marshall; Haiyen E Zhau; Leland W K Chung
PrLZ, a novel prostate-specific and androgen-responsive gene of the TPD52 family, amplified in chromosome 8q21.1 and overexpressed in human prostate cancer.
Cancer research 2004;64(5):1589-94.
2004: Marika J Linja; Kati P Porkka; Zhikang Kang; Kimmo Savinainen; Olli A Jänne; Teuvo L J Tammela; Robert L Vessella; Jorma J Palvimo; Tapio Visakorpi
Expression of androgen receptor coregulators in prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(3):1032-40.
2004: Nina N Nupponen; Mika J Wallén; Damaris Ponciano; Christiane M Robbins; Teuvo L J Tammela; Robert L Vessella; John D Carpten; Tapio Visakorpi
Mutational analysis of susceptibility genes RNASEL/HPC1, ELAC2/HPC2, and MSR1 in sporadic prostate cancer.
Genes, chromosomes & cancer 2004;39(2):119-25.
2004: Marije M Vleugel; Reinhard Bos; Horst Buerger; Petra van Der Groep; Outi Saramäki; Tapio Visakorpi; ELSKEN VAN DER WALL; Paulus van Diest
No amplifications of hypoxia-inducible factor-1alpha gene in invasive breast cancer: a tissue microarray study.
Cellular oncology : the official journal of the International Society for Cellular Oncology 2004;26(5-6):347-51.
2004: Kati P Porkka; Teuvo L J Tammela; Robert L Vessella; Tapio Visakorpi
RAD21 and KIAA0196 at 8q24 are amplified and overexpressed in prostate cancer.
Genes, chromosomes & cancer 2004;39(1):1-10.
2003: Teemu T Junttila; Matti Laato; Tero Vahlberg; Karl-Ove Söderström; Tapio Visakorpi; Jorma Isola; Klaus Elenius
Identification of patients with transitional cell carcinoma of the bladder overexpressing ErbB2, ErbB3, or specific ErbB4 isoforms: real-time reverse transcription-PCR analysis in estimation of ErbB receptor status from cancer patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(14):5346-57.
2003: Tapio Visakorpi
The molecular genetics of prostate cancer.
Urology 2003;62(5 Suppl 1):3-10.
2003: Kati P Porkka; Nina N Nupponen; Teuvo L J Tammela; Robert L Vessella; Tapio Visakorpi
Human pHyde is not a classical tumor suppressor gene in prostate cancer.
International journal of cancer. Journal international du cancer 2003;106(5):729-35.
2003: Marika J Linja; Kimmo Savinainen; Teuvo L J Tammela; Jorma Isola; Tapio Visakorpi
Expression of ERalpha and ERbeta in prostate cancer.
The Prostate 2003;55(3):180-6.
2002: Kati P Porkka; Merja A Helenius; Tapio Visakorpi
Cloning and characterization of a novel six-transmembrane protein STEAP2, expressed in normal and malignant prostate.
Laboratory investigation; a journal of technical methods and pathology 2002;82(11):1573-82.
2002: Sari Laitinen; Ritva Karhu; Charles L Sawyers; Robert L Vessella; Tapio Visakorpi
Chromosomal aberrations in prostate cancer xenografts detected by comparative genomic hybridization.
Genes, chromosomes & cancer 2002;35(1):66-73.
2002: Wolfgang A Schulz; Jussi P Elo; Andrea R Florl; Sari Pennanen; Simeon Santourlidis; Rainer Engers; Martin Buchardt; Hans-Helge Seifert; Tapio Visakorpi
Genomewide DNA hypomethylation is associated with alterations on chromosome 8 in prostate carcinoma.
Genes, chromosomes & cancer 2002;35(1):58-65.
2002: Maija Kiuru; Rainer Lehtonen; Johanna Arola; Reijo Salovaara; Heikki Järvinen; Kristiina Aittomäki; Jari Sjöberg; Tapio Visakorpi; Sakari Knuutila; Jorma Isola; Brett Delahunt; Riitta Herva; Virpi Launonen; Auli Karhu; Lauri A Aaltonen
Few FH mutations in sporadic counterparts of tumor types observed in hereditary leiomyomatosis and renal cell cancer families.
Cancer research 2002;62(16):4554-7.
2002: Minna M Joki-Erkkilä; Riitta Karikoski; Immo Rantala; Hanna-Liisa Lenko; Tapio Visakorpi; Pentti K Heinonen
Gonadoblastoma and dysgerminoma associated with XY gonadal dysgenesis in an adolescent with chronic renal failure: a case of Frasier syndrome.
Journal of pediatric and adolescent gynecology 2002;15(3):145-9.
2002: Kati P Porkka; Outi Saramäki; Minna Tanner; Tapio Visakorpi
Amplification and overexpression of Elongin C gene discovered in prostate cancer by cDNA microarrays.
Laboratory investigation; a journal of technical methods and pathology 2002;82(5):629-37.
2002: Barbara Leube; Matthias Drechsler; Kristina Mühlmann; Reinhold Schäfer; Wolfgang A Schulz; Simeon Santourlidis; Aristotelis G Anastasiadis; Rolf Ackermann; Tapio Visakorpi; Wolfram Müller; Brigitte Royer-Pokora
Refined mapping of allele loss at chromosome 10q23-26 in prostate cancer.
The Prostate 2002;50(3):135-44.
2002: Kimmo Savinainen; Outi Saramäki; Marika J Linja; Ola Bratt; Teuvo L J Tammela; Jorma Isola; Tapio Visakorpi
Expression and gene copy number analysis of ERBB2 oncogene in prostate cancer.
The American journal of pathology 2002;160(1):339-45.
2001: Outi Saramäki; Niels Willi; Ola Bratt; Thomas C Gasser; Pasi A Koivisto; Nina N Nupponen; Lukas Bubendorf; Tapio Visakorpi
Amplification of EIF3S3 gene is associated with advanced stage in prostate cancer.
The American journal of pathology 2001;159(6):2089-94.
2001: Merja A Helenius; Outi Saramäki; Marika J Linja; Teuvo L J Tammela; Tapio Visakorpi
Amplification of urokinase gene in prostate cancer.
Cancer research 2001;61(14):5340-4.
2001: Outi Saramäki; Kimmo Savinainen; Nina N Nupponen; Ola Bratt; Tapio Visakorpi
Amplification of hypoxia-inducible factor 1alpha gene in prostate cancer.
Cancer genetics and cytogenetics 2001;128(1):31-4.
2001: Jorma Isola; Anssi Auvinen; M Poutiainen; L Kakkola; Tero A H Järvinen; Liisa Määttänen; Ulf-Hakan Stenman; T Tammela; Matti Hakama; Tapio Visakorpi
Predictors of biological aggressiveness of prostate specific antigen screening detected prostate cancer.
The Journal of urology 2001;165(5):1569-74.
2001: Marika J Linja; Kimmo Savinainen; Outi Saramäki; Teuvo L J Tammela; Robert L Vessella; Tapio Visakorpi
Amplification and overexpression of androgen receptor gene in hormone-refractory prostate cancer.
Cancer research 2001;61(9):3550-5.
2001: J P Elo; Tapio Visakorpi
Molecular genetics of prostate cancer.
Annals of medicine 2001;33(2):130-41.
2001: Y Pan; Weng-Onn Lui; Nina N Nupponen; Catharina Larsson; Jorma Isola; Tapio Visakorpi; Ulf Bergerheim; Soili Kytölä
5q11, 8p11, and 10q22 are recurrent chromosomal breakpoints in prostate cancer cell lines.
Genes, chromosomes & cancer 2001;30(2):187-95.
2001: Kati P Porkka; Tapio Visakorpi
Detection of differentially expressed genes in prostate cancer by combining suppression subtractive hybridization and cDNA library array.
The Journal of pathology 2001;193(1):73-9.
2000: C Palmberg; Pasi A Koivisto; L Kakkola; Teuvo L J Tammela; Olli Kallioniemi; Tapio Visakorpi
Androgen receptor gene amplification at primary progression predicts response to combined androgen blockade as second line therapy for advanced prostate cancer.
The Journal of urology 2000;164(6):1992-5.
2000: Eivor Hernes; Marika J Linja; Sophie D Fosså; Tapio Visakorpi; Aasmund Berner; Mette Winderen; P A Koivisto
Hormone-resistant prostate cancer with symptomatic pelvic tumours: patient survival and prognostic factors.
BJU international 2000;86(3):240-7.
2000: Nina N Nupponen; Jorma Isola; Tapio Visakorpi
Mapping the amplification of EIF3S3 in breast and prostate cancer.
Genes, chromosomes & cancer 2000;28(2):203-10.
1999: Mika J Wallén; Marika J Linja; K Kaartinen; Johanna Schleutker; Tapio Visakorpi
Androgen receptor gene mutations in hormone-refractory prostate cancer.
The Journal of pathology 1999;189(4):559-63.
1999: C Palmberg; Pasi A Koivisto; Tapio Visakorpi; Teuvo L J Tammela
PSA decline is an independent prognostic marker in hormonally treated prostate cancer.
European urology 1999;36(3):191-6.
1999: Nina N Nupponen; Kati P Porkka; L Kakkola; Minna Tanner; K Persson; Ake Borg; Jorma Isola; Tapio Visakorpi
Amplification and overexpression of p40 subunit of eukaryotic translation initiation factor 3 in breast and prostate cancer.
The American journal of pathology 1999;154(6):1777-83.
1999: Y Pan; Soili Kytölä; Filip Farnebo; N Wang; Weng-Onn Lui; Nina N Nupponen; Jorma Isola; Tapio Visakorpi; Ulf Bergerheim; Catharina Larsson
Characterization of chromosomal abnormalities in prostate cancer cell lines by spectral karyotyping.
Cytogenetics and cell genetics 1999;87(3-4):225-32.
1999: Nina N Nupponen; Tapio Visakorpi
Assignment of the protein kinase homolog of YAK1 (HIPK3) to human chromosome band 11p13 by in situ hybridization.
Cytogenetics and cell genetics 1999;87(1-2):102-3.
1999: Nina N Nupponen; Tapio Visakorpi
Molecular biology of progression of prostate cancer.
European urology 1999;35(5-6):351-4.
1999: Tapio Visakorpi
Molecular genetics of prostate cancer.
Annales chirurgiae et gynaecologiae 1999;88(1):11-6.
1998: Nina N Nupponen; L Kakkola; Pasi A Koivisto; Tapio Visakorpi
Genetic alterations in hormone-refractory recurrent prostate carcinomas.
The American journal of pathology 1998;153(1):141-8.
1998: Nina N Nupponen; Eija-Riitta Hyytinen; Anne Kallioniemi; Tapio Visakorpi
Genetic alterations in prostate cancer cell lines detected by comparative genomic hybridization.
Cancer genetics and cytogenetics 1998;101(1):53-7.
1998: Pasi A Koivisto; M Kolmer; Tapio Visakorpi; Olli Kallioniemi
Androgen receptor gene and hormonal therapy failure of prostate cancer.
The American journal of pathology 1998;152(1):1-9.
1997: Pasi A Koivisto; Tapio Visakorpi; Immo Rantala; Jorma Isola
Increased cell proliferation activity and decreased cell death are associated with the emergence of hormone-refractory recurrent prostate cancer.
The Journal of pathology 1997;183(1):51-6.
1997: Tuula Kuukasjärvi; Minna Tanner; Sari Pennanen; Ritva Karhu; Tapio Visakorpi; Jorma Isola
Optimizing DOP-PCR for universal amplification of small DNA samples in comparative genomic hybridization.
Genes, chromosomes & cancer 1997;18(2):94-101.
1997: Pasi A Koivisto; Juha Kononen; C Palmberg; T Tammela; Eija-Riitta Hyytinen; Jorma Isola; J Trapman; Kitty B J M Cleutjens; A Noordzij; Tapio Visakorpi; Olli Kallioniemi
Androgen receptor gene amplification: a possible molecular mechanism for androgen deprivation therapy failure in prostate cancer.
Cancer research 1997;57(2):314-9.
1997: C Palmberg; Pasi A Koivisto; Eija-Riitta Hyytinen; Jorma Isola; Tapio Visakorpi; Olli Kallioniemi; T Tammela
Androgen receptor gene amplification in a recurrent prostate cancer after monotherapy with the nonsteroidal potent antiandrogen Casodex (bicalutamide) with a subsequent favorable response to maximal androgen blockade.
European urology 1997;31(2):216-9.
1997: Eija-Riitta Hyytinen; G N Thalmann; Haiyen E Zhau; Ritva Karhu; Olli Kallioniemi; Leland W K Chung; Tapio Visakorpi
Genetic changes associated with the acquisition of androgen-independent growth, tumorigenicity and metastatic potential in a prostate cancer model.
British journal of cancer 1997;75(2):190-5.
1996: Matti Hakama; Kaija Holli; Tapio Visakorpi; M Pekola; Olli Kallioniemi
Low biological aggressiveness of screen-detected lung cancers may indicate over-diagnosis.
International journal of cancer. Journal international du cancer 1996;66(1):6-10.
1996: V Vuorinen; Pauli Sallinen; H Haapasalo; Tapio Visakorpi; M Kallio; Juha Jääskeläinen
Outcome of 31 intracranial haemangiopericytomas: poor predictive value of cell proliferation indices.
Acta neurochirurgica 1996;138(12):1399-408.
1996: Pasi A Koivisto; Tapio Visakorpi; Olli Kallioniemi
Androgen receptor gene amplification: a novel molecular mechanism for endocrine therapy resistance in human prostate cancer.
Scandinavian journal of clinical and laboratory investigation. Supplementum 1996;226():57-63.
1995: Pasi A Koivisto; Eija-Riitta Hyytinen; C Palmberg; T Tammela; Tapio Visakorpi; Jorma Isola; Olli Kallioniemi
Analysis of genetic changes underlying local recurrence of prostate carcinoma during androgen deprivation therapy.
The American journal of pathology 1995;147(6):1608-14.
1995: Tapio Visakorpi; Eija-Riitta Hyytinen; Pasi A Koivisto; M Tanner; R Keinänen; C Palmberg; A Palotie; T Tammela; Jorma Isola; Olli Kallioniemi
In vivo amplification of the androgen receptor gene and progression of human prostate cancer.
Nature genetics 1995;9(4):401-6.
1995: Matti Hakama; Kaija Holli; Jorma Isola; Olli Kallioniemi; A Kärkkäinen; Tapio Visakorpi; E Pukkala; IE Saarenmaa; U Geiger; J Ikkala
Aggressiveness of screen-detected breast cancers.
Lancet 1995;345(8944):221-4.
1995: Tapio Visakorpi; Anne Kallioniemi; A C Syvänen; Eija-Riitta Hyytinen; Ritva Karhu; T Tammela; J J Isola; Olli Kallioniemi
Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization.
Cancer research 1995;55(2):342-7.
1995: Tapio Visakorpi; Kaija Holli; M Hakama
High cell proliferation activity determined by DNA flow cytometry and prognosis in epidermoid lung carcinoma.
Acta oncologica (Stockholm, Sweden) 1995;34(5):605-9.
1994: Pauli Sallinen; Hannu Haapasalo; Tapio Visakorpi; Pauli Helén; Immo Rantala; J J Isola; Heikki Helin
Prognostication of astrocytoma patient survival by Ki-67 (MIB-1), PCNA, and S-phase fraction using archival paraffin-embedded samples.
The Journal of pathology 1994;174(4):275-82.
1994: Tapio Visakorpi; Eija-Riitta Hyytinen; Anne Kallioniemi; Jorma Isola; Olli Kallioniemi
Sensitive detection of chromosome copy number aberrations in prostate cancer by fluorescence in situ hybridization.
The American journal of pathology 1994;145(3):624-30.
1994: Olli Kallioniemi; Tapio Visakorpi; Kaija Holli; J J Isola; P S Rabinovitch
Automated peak detection and cell cycle analysis of flow cytometric DNA histograms.
Cytometry 1994;16(3):250-5.
1994: Eija-Riitta Hyytinen; Tapio Visakorpi; Anne Kallioniemi; Olli Kallioniemi; J J Isola
Improved technique for analysis of formalin-fixed, paraffin-embedded tumors by fluorescence in situ hybridization.
Cytometry 1994;16(2):93-9.
1994: Tapio Visakorpi; Timo Kylmälä; H Tainio; T Koivula; T Tammela; J Isola
High cell proliferation activity determined by DNA flow cytometry predicts poor prognosis after relapse in prostate cancer.
European journal of cancer (Oxford, England : 1990) 1994;30A(1):129-30.
1993: Tapio Visakorpi; Olli Kallioniemi; Timo Koivula; Jorma Isola
New prognostic factors in prostatic carcinoma.
European urology 1993;24(4):438-49.
1993: Jorma Isola; S Weitz; Tapio Visakorpi; Kaija Holli; R Shea; N Khabbaz; Olli Kallioniemi
Cathepsin D expression detected by immunohistochemistry has independent prognostic value in axillary node-negative breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(1):36-43.
1992: Tapio Visakorpi; Olli Kallioniemi; T Koivula; J Harvey; J Isola
Expression of epidermal growth factor receptor and ERBB2 (HER-2/Neu) oncoprotein in prostatic carcinomas.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 1992;5(6):643-8.
1992: Tapio Visakorpi
Proliferative activity determined by DNA flow cytometry and proliferating cell nuclear antigen (PCNA) immunohistochemistry as a prognostic factor in prostatic carcinoma.
The Journal of pathology 1992;168(1):7-13.
1992: Jorma Isola; Tapio Visakorpi; Kaija Holli; Olli Kallioniemi
Association of overexpression of tumor suppressor protein p53 with rapid cell proliferation and poor prognosis in node-negative breast cancer patients.
Journal of the National Cancer Institute 1992;84(14):1109-14.
1992: Tapio Visakorpi; Olli Kallioniemi; A Heikkinen; Timo Koivula; Jorma Isola
Small subgroup of aggressive, highly proliferative prostatic carcinomas defined by p53 accumulation.
Journal of the National Cancer Institute 1992;84(11):883-7.
1991: Olli Kallioniemi; Kaija Holli; Tapio Visakorpi; Timo Koivula; H H Helin; J J Isola
Association of c-erbB-2 protein over-expression with high rate of cell proliferation, increased risk of visceral metastasis and poor long-term survival in breast cancer.
International journal of cancer. Journal international du cancer 1991;49(5):650-5.
1991: M Hyöty; Tapio Visakorpi; Olli Kallioniemi; J Mattila; P Laippala; Isto Nordback
Prognostic value of analysis of DNA in pancreatic adenocarcinoma by flow cytometry.
The European journal of surgery = Acta chirurgica 1991;157(10):595-600.
1991: Tapio Visakorpi; Olli Kallioniemi; I Y Paronen; J J Isola; A I Heikkinen; Timo Koivula
Flow cytometric analysis of DNA ploidy and S-phase fraction from prostatic carcinomas: implications for prognosis and response to endocrine therapy.
British journal of cancer 1991;64(3):578-82.
1991: Olli Kallioniemi; Tapio Visakorpi; Kaija Holli; A Heikkinen; Jorma Isola; Timo Koivula
Improved prognostic impact of S-phase values from paraffin-embedded breast and prostate carcinomas after correcting for nuclear slicing.
Cytometry 1991;12(5):413-21.
1991: Olli Kallioniemi; Kaija Holli; Tapio Visakorpi; T Koivula; Heikki Helin; Jorma Isola
[New studies on breast cancer to predict disease outcome and clinical use of these new tests].
Duodecim; lääketieteellinen aikakauskirja 1991;107(11):907-16.
1987: Tapio Visakorpi; P Vilja; M Kulomaa; Pentti Tuohimaa; M Klockars
Cerebrospinal fluid lactoferrin in bacterial and viral meningitis.
Acta paediatrica Scandinavica 1987;76(6):987-8.